Healthleap raises $38 million for hospital risk-flagging AI

Healthleap was founded in South Africa in 2022 by siblings Jemima and Josiah Meyer. It began with a clinical nutrition tool Jemima had built for dietitians, then pivoted to a broader platform aimed at spotting hospital patients whose conditions are not identified early enough. That pivot helps explain why malnutrition and delirium anchor the current product: malnutrition is the kind of condition that often goes undiagnosed, and research cited in the article suggests 20% to 50% of hospital inpatients are malnourished. Some studies have linked malnutrition with longer stays, impaired wound healing, infections and other complications, as well as higher morbidity and mortality.

The commercial story in the article is largely about scale rather than a single sale. Josiah Meyer said Healthleap grew from three hospital partners to more than 50 over the past year, and its customers now include Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist and Emory Healthcare. Revenue grew more than 10x over that period, though he did not disclose specifics, and the company is not disclosing its valuation. The company also cites an outcome-based pricing model and says every customer has seen a 5x hard ROI or more, with some above 20x annual total ROI. At the Hospital of the University of Pennsylvania, Healthleap says its malnutrition program produced $23.8 million in annualized financial impact, split between $6.3 million from additional reimbursement and $17.5 million from shorter hospital stays.

What happens next appears to hinge less on the funding itself and more on whether the newer condition programs clear clinical validation. Meyer said the money will go to engineering, product, sales, and customer success, and that the longer-term ambition is to cover more than 40 major health conditions and move into outpatient and home care. Whether hospital finance teams keep validating the claimed ROI at the same rates may determine how quickly that expansion translates into contracts.